Sangamo Biosciences, Inc. (SGMO) Posts Q1 Loss of 12c/Share

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)